Vinge advises Litorina V in connection with the acquisition of Sushi Yama

Sushi Yama is a leading sushi restaurant chain with over 45 restaurants in Sweden.

Vinge advises SBB in connection with an issue of D shares and mandatory convertibles

The board of directors of Samhällsbyggnadsbolaget i Norden has, on the basis of an authorization granted by the annual general meeting, resolved on a directed issue of class D shares and a directed issue of subordinated convertibles mandatorily convertible into class B shares, whereby the company raises proceeds of SEK 3.4 billion before issue costs.

Vinge advises Danir Resources on its acquisition of the Örås family’s shares in Poolia

Danir Resources AB has entered into an agreement to acquire the Björn Örås family’s shares in Poolia AB (publ).

Vinge advises BHG Group on its takeover bid for Sleepo

BHG Group AB (publ) has made a recommended cash offer to the shareholders of Sleepo AB (publ).

Vinge advised the founders in relation to Verdane's investment

Vinge advised the founders in relation to Verdane's investment in Caia Cosmetics.

Vinge has advised SCA in connection with the financing of the investment in the Obbola kraftliner mill

The total investment for Svenska Cellulosa Aktiebolaget SCA (publ) (”SCA”) amounts to SEK 7.5 billion over a five-year period.

Vinge has advised Scandic in connection with its rights issue and the agreement on new credit facilities

Vinge has advised Scandic Hotels Group AB (publ) on a fully underwritten rights issue, which will provide Scandic with issue proceeds amounting up to approximately SEK 1,765 million before deduction of transaction costs, and on the agreement of new credit facilities amounting to SEK 1,400 million.

Vinge advises Alfa Laval on its takeover bid for Neles

Alfa Laval AB (publ) has announced a recommended public cash offer to the shareholders of Neles Corporation.

Vinge advises Hansa Biopharma in connection with a directed share issue

The board of directors of Hansa Biopharma has, on the basis of an authorisation granted from the annual general meeting, resolved on a directed new issue of shares, whereby Hansa Biopharma will raise proceeds of SEK 1.1 billion, before issue costs.

Vinge advised Trianon on directed share issue

Vinge advised Fastighets AB Trianon in connection with a directed share issue of SEK 115 million through an accelerated book building procedure.

Vinge has advised Vicore Pharma in connection with a directed share issue of approximately SEK 185 million

Vinge has advised Vicore Pharma, a Swedish rare disease company focused on interstitial lung diseases and related indications, in connection with a directed share issue whereby Vicore Pharma will receive approximately SEK 185 million in issue proceeds.

Vinge advises Cinven’s portfolio company Partner in Pet Food in connection with its acquisition of the Doggy

Vinge advises Cinven’s portfolio company Partner in Pet Food, a leading European pet food manufacturer, in connection with its acquisition of the Doggy Group (“Doggy”).

Vinge advises the sellers in the sale of Larodan AB to ABITEC Corporation

Vinge advises the owners of Larodan AB in the sale of the company to ABITEC Corporation, a subsidiary in the listed corporate group Associated British Foods, plc (“ABF”).

Vinge advised IVISYS on directed share issue

Vinge advised IVISYS AB in connection with a directed share issue through an accelerated book building procedure.

Vinge has advised Axcel on its investment in AddPro

Axcel has signed an agreement to aquire a majority ownership stake in AddPro, a Swedish leading provider of IT and cloud services. AddPro’s current management team and founders will reinvest in the company alongside Axcel.